Jump to main content
Volume number2 (7)
既存治療が効果不十分...

既存治療が効果不十分または不適当な真性多血症患者に対するロペグインターフェロンα-2bの費用対効果評価

Icons representing 記事
The cover of this title could differ from library to library. Link to Help Page

既存治療が効果不十分または不適当な真性多血症患者に対するロペグインターフェロンα-2bの費用対効果評価

Persistent ID (NDL)
info:ndljp/pid/14712659
Material type
記事
Author
下畑宣行ほか
Publisher
国立保健医療科学院
Publication date
2024
Material Format
Digital
Journal name
Academic technology assessment group (ATAG) reports 2(7)
Publication Page
-
View All

Notes on use

Note (General):

一部被覆あり

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
記事
Author/Editor
下畑宣行
岩本哲哉
田中素子
星野絵里
白岩健
阿久根陽子
後藤励
福田敬
Publication, Distribution, etc.
Publication Date
2024
Publication Date (W3CDTF)
2024
Alternative Title
Cost-effectiveness evaluation of ropeginterferon α-2b for polycythemia vera patients who have an inadequate response or intolerance to existing treatments
Periodical title
Academic technology assessment group (ATAG) reports
No. or year of volume/issue
2(7)
Volume
2(7)